As the popularity of weight-loss drugs skyrockets, so does the need for more coverage, more upfront investments, and the risk of increased cost per patient.

In this clip from our recent episode, "The Cost Crisis of Weight Loss Drugs", John Driscoll unpacks the price paradox providers face as they balance the health outcomes of covered lives with the mounting financial costs.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

📥 GET IN TOUCH
Become a CareTalk Podcast sponsor: https://www.caretalkpodcast.com/work-...
Guest appearance requests: https://www.caretalkpodcast.com/conta...
Visit us at https://www.caretalkpodcast.com

📲 FOLLOW
Spotify: https://open.spotify.com/show/2GTYhbN....
Apple Podcasts: https://podcasts.apple.com/us/podcast....
Follow us on LinkedIn:   / caretalk-podcast  

🗞️ Subscribe to our newsletter: https://www.caretalkpodcast.com/newsl...
🛒 Shop for official CareTalk merch: https://www.caretalkpodcast.com/categ...

⚙️ Produced by Grippi Media: https://www.grippimedia.com

#healthcarepodcast #healthcare #weightloss #weightlossdrugs #drugpricing #GLP1 #medicalcosts